Day 1 (2023)
Over the past 50 years, our mission at the National Headache Foundation has been to further awareness of headache and migraine as legitimate neurobiological diseases. Much has changed during this time. With aid from advanced technology and clinical innovation, there are more treatment options than ever before. However, we understand that these diseases are still largely misunderstood and that finding the right treatment options for you requires insight.
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, and LinkedIn.
Watch videos in silence or read along with the expert interview. Simply turn on CC in video controls in the lower right corner of the video. Note: closed captions are not available on preview videos or extended editions.
Today's Interviews
Innovations in Migraine Treatment & Therapies
Stewart J. Tepper, MD
Professor of Neurology
Geisel School of Medicine at Dartmouth
Beyond the Pain: Other Migraine Symptoms
Nazia Karsan, MRCP, PhD
Postdoctoral Clinical Fellow
King's College London
Brain Retraining for Chronic Pain
Bethany Ranes, PhD
Chief Scientific Officer
Healing Track (forthcoming)
Diminishing Migraine-Related Stigma and Advocating for Your Health
Bert Vargas, MD
Associate Vice President, U.S. Medical Affairs-Neuroscience
Eli Lilly and Company
Purchase full access to the entire 2024 Summit. Includes:
- All expert interviews with separate audio (MP3) files & transcripts
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Guidelines
- And much more!
